Marie Johnson, PhD

Marie Johnson, PhD, Founder & CEO, AUM Cardiovascular, Speaker Rosenman Institute

Dr. Marie Johnson is CEO and President of AUM Cardiovascular, Inc., a Northfield, Minnesota based medical device company developing game-changing […]

Tippi MacKenzie

Tippi MacKenzie, Professor of Surgery, UCSF, & Co-Director, UCSF Center for Maternal-Fetal Precision Medicine, Speaker UCSF Rosenman Institute

Tippi MacKenzie is a pediatric and fetal surgeon who is focused on developing better ways to diagnose and treat genetic […]

Harith Rajagopalan, MD, PhD

Harith Rajagopalan, MD, PhD, Co-Founder and CEO, Fractyl, Speaker UCSF Rosenman Institute

Harith Rajagopalan, M.D., Ph.D., is Co-founder and CEO of Fractyl, having started the company while serving as an Entrepreneur-in-Residence at […]

Stanton J. Rowe

Stanton J. Rowe, CEO, NXT BiomedicalStanton J. Rowe, CEO, NXT Biomedical, Speaker UCSF Rosenman Institute

Stanton J. Rowe is CEO of NXT Biomedical, a medical device incubator funded by Deerfield Capital. Stanton recently retired from […]

Ruchita Sinha

Ruchita Sinha, Senior Director of Investments, Sanofi Ventures, , Speaker UCSF Rosenman Institute

Ruchita joined Sanofi Ventures in 2016 with a relevant background in digital health. Prior to Sanofi, Ruchita was at GE […]

Joe DeSimone, PhD

Dr. Joseph M. DeSimone is the CEO/Co-founder of Carbon, Inc. located in Silicon Valley. Prior to this, DeSimone was the […]

Thomas Tsang, MD, MPH

He was the former CMO at a Merck subsidiary focused on commercializing digital solutions. Prior to Merck, Tom was part […]

Wende Hutton

Wende Hutton, General Partner, Canaan Partners, Speaker UCSF Rosenman Institute

Wende identifies, builds and invests in companies that change medicine by bringing novel drugs, technologies and devices to market. She […]

Tina Ivovic

Tina Ivovic, Senior Director, Global Field Health Economics and Reimbursement, Abbott, Speaker UCSF Rosenman Institute

Tina Ivovic is an expert in Medical Device Reimbursement with a focus on Medicare and Commercial payer policy development, administrative […]